B Muñoz1, S K West. 1. Dana Center, Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD 21287, USA.
Abstract
AIM: To summarise available data on the prevalence and causes of visual impairment and blindness in the Americas and the Caribbean. METHODS: The published literature was searched in Medline and LILACS using the following key words: blindness, visual impairment, prevalence. Articles were reviewed, and the references of the articles were also searched for relevant articles, which were also reviewed. RESULTS: Using the mortality in children under the age of 5 as an indicator, the overall prevalence of childhood blindness (in the under age 15 group) for the region was estimated at 0.45/1000, with the majority (67%) living in countries with mortality of children under age 5 above 30/1000 live births. Corneal opacities were more common in countries where the under 5 year mortality are above 30/1000 live births and retinopathy of prematurity (ROP) was an important cause in countries with intermediate death rates. For adults, overall blindness rates were not estimated because of the social, economic, and ethnic diversity in the region. The primary causes of visual loss in adults in the Americas were age related eye diseases, notably cataract and glaucoma in the African-American and Hispanic populations, and age related macular degeneration in the white population. Uncorrected refractive error was a significant cause of decreased vision across ages, ethnic groups, and countries. CONCLUSION: More data are needed on the magnitude and causes of visual loss for the Caribbean and Latin American countries. Rates of blindness and visual loss from available data within these countries are widely disparate. Prevention and control of avoidable blindness needs to be an ongoing focus in this region.
AIM: To summarise available data on the prevalence and causes of visual impairment and blindness in the Americas and the Caribbean. METHODS: The published literature was searched in Medline and LILACS using the following key words: blindness, visual impairment, prevalence. Articles were reviewed, and the references of the articles were also searched for relevant articles, which were also reviewed. RESULTS: Using the mortality in children under the age of 5 as an indicator, the overall prevalence of childhood blindness (in the under age 15 group) for the region was estimated at 0.45/1000, with the majority (67%) living in countries with mortality of children under age 5 above 30/1000 live births. Corneal opacities were more common in countries where the under 5 year mortality are above 30/1000 live births and retinopathy of prematurity (ROP) was an important cause in countries with intermediate death rates. For adults, overall blindness rates were not estimated because of the social, economic, and ethnic diversity in the region. The primary causes of visual loss in adults in the Americas were age related eye diseases, notably cataract and glaucoma in the African-American and Hispanic populations, and age related macular degeneration in the white population. Uncorrected refractive error was a significant cause of decreased vision across ages, ethnic groups, and countries. CONCLUSION: More data are needed on the magnitude and causes of visual loss for the Caribbean and Latin American countries. Rates of blindness and visual loss from available data within these countries are widely disparate. Prevention and control of avoidable blindness needs to be an ongoing focus in this region.
Authors: M Wilson; E Keyvan-Larijani; F Millan-Velasco; J M Tielsch; H R Taylor Journal: Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique Date: 1987
Authors: Rony Gelman; Lei Jiang; Yunling E Du; M Elena Martinez-Perez; John T Flynn; Michael F Chiang Journal: J AAPOS Date: 2007-10-29 Impact factor: 1.220
Authors: Michael F Chiang; Rony Gelman; Steven L Williams; Joo-Yeon Lee; Daniel S Casper; M Elena Martinez-Perez; John T Flynn Journal: Invest Ophthalmol Vis Sci Date: 2008-04-11 Impact factor: 4.799
Authors: Hilal Biten; Travis K Redd; Chace Moleta; J Peter Campbell; Susan Ostmo; Karyn Jonas; R V Paul Chan; Michael F Chiang Journal: JAMA Ophthalmol Date: 2018-05-01 Impact factor: 7.389
Authors: Jane S Myung; Rony Gelman; Grant D Aaker; Nathan M Radcliffe; R V Paul Chan; Michael F Chiang Journal: Am J Ophthalmol Date: 2011-10-22 Impact factor: 5.258
Authors: Isabel Signes-Soler; José Luis Hernández-Verdejo; Miguel Angel Estrella Lumeras; Elena Tomás Verduras; David P Piñero Journal: Int J Ophthalmol Date: 2017-03-18 Impact factor: 1.779
Authors: Hui Chen; Ying-Chuan Fan; Qi-Hong He; Xiao-Yun Wu; Min Wei; June E Eichner; Bradley K Farris; P Lloyd Hildebrand; Chun-Tao Lei; Shu-Hua Wu; Jing-Yun Yang Journal: Int J Ophthalmol Date: 2014-02-18 Impact factor: 1.779
Authors: Joo-Yeon Lee; Yunling E Du; Osode Coki; John T Flynn; Justin Starren; Michael F Chiang Journal: Graefes Arch Clin Exp Ophthalmol Date: 2009-09-23 Impact factor: 3.117